CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol.36, no.6, 2018 (Journal Indexed in SCI)
Article / Article
Title of Journal :
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
familial Mediterranean fever, colchicine resistance, colchicine unresponsiveness, RECOMMENDATIONS, ASSOCIATION, MANAGEMENT, DIAGNOSIS, ANAKINRA, CRITERIA, CHILDREN, SCORE, FMF
Objective. Colchicine is the main therapy for familial Mediterranean fever (FMF); however, 5-10% of patients are colchicine-resistant. There is no standard and validated definition for colchicine resistance. We aimed to compare the existing definitions for colchicine resistance in both adult and paediatric FMF patients to find out the best definition to determine colchicine-resistant patients.